Connect with us

Health

Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages – News-Medical.Net

Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses…

Published

on

Article feature image

Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The researchers from CureVac AG in Tübingen and the Friedrich-Loeffler-Institute in Greifswald-Insel Riems say that compared with their previous vaccine candidate – CvnCoV – the second-generation CV2CoV vaccine accelerated induction of neutralizing antibody titers…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
The ‘inhumane’ way WA is dealing with children with anorexia – The West Australian
Article feature image
Coronavirus Vaccine: Getting your second COVID-19 vaccine jab? Here’s what you can expect – GM Newshub – GM Newshub